MARKET

OBIO

OBIO

Orchestra BioMed Holdings Inc
NASDAQ
4.500
-0.140
-3.02%
After Hours: 4.500 0 0.00% 16:00 04/22 EDT
OPEN
4.670
PREV CLOSE
4.640
HIGH
4.670
LOW
4.460
VOLUME
49.13K
TURNOVER
0
52 WEEK HIGH
22.91
52 WEEK LOW
4.255
MARKET CAP
161.00M
P/E (TTM)
-3.0438
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at OBIO last week (0415-0419)?
Weekly Report · 9h ago
Weekly Report: what happened at OBIO last week (0408-0412)?
Weekly Report · 04/15 11:56
Weekly Report: what happened at OBIO last week (0401-0405)?
Weekly Report · 04/08 12:03
Weekly Report: what happened at OBIO last week (0325-0329)?
Weekly Report · 04/01 12:00
Orchestra BioMed Holdings Inc: Statement of changes in beneficial ownership of securities
Press release · 03/29 02:34
Orchestra BioMed Hldgs Price Target Maintained With a $20.00/Share by Chardan Capital
Dow Jones · 03/28 12:59
Orchestra BioMed Hldgs Is Maintained at Buy by Chardan Capital
Dow Jones · 03/28 12:59
Chardan Capital Maintains Buy on Orchestra BioMed Hldgs, Maintains $20 Price Target
Benzinga · 03/28 12:49
More
About OBIO
Orchestra BioMed Holdings, Inc. is a biomedical innovation company seeking to provide solutions for unmet needs in procedure-based medicine. The Company’s flagship product candidates are Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of artery disease, the leading cause of mortality worldwide, and BackBeat Cardiac Neuromodulation Therapy (BackBeat CNT) for the treatment of hypertension, a significant risk factor for death worldwide. Virtue SAB is a drug/device combination product candidate for the treatment of artery disease designed to deliver an extended-release formulation of sirolimus, SirolimusEFR, during balloon angioplasty without the need for balloon coating or a permanent implant. BackBeat CNT is a bioelectronic treatment for hypertension that is designed to drive an immediate, substantial and persistent reduction in blood pressure while simultaneously modulating autonomic nervous system responses to maintain the reduction.

Webull offers Orchestra Biomed Holdings Inc stock information, including NASDAQ: OBIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OBIO stock methods without spending real money on the virtual paper trading platform.